Home › Shire to Combine with Baxalta in Deal Valued at About $32 Billion
 

Keywords :   


Shire to Combine with Baxalta in Deal Valued at About $32 Billion

2016-01-11 14:23:03| Biotech - Topix.net

Shire Plc agreed to buy Baxalta Inc. for about $32 billion to become the world's biggest maker of so-called orphan drugs for rare diseases. The price includes 0.1482 of Shire's American depositary receipts and $18 in cash for each Baxalta share held, the Dublin-based drugmaker said in a statement.

Tags: deal billion combine valued

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
09.10Nuclear plant 'will decimate fish stocks'
09.10Hurricane Milton Public Advisory Number 16A
09.10Summary for Hurricane Milton (AT4/AL142024)
09.10Eastern North Pacific Tropical Weather Outlook
09.10Atlantic Tropical Weather Outlook
09.10US says it may break up Google after landmark case
09.10Boeing withdraws 30% pay rise offer to striking staff
09.10Hurricane Milton Potential Storm Surge Flooding Map
More »